CEO Message

"I am very pleased to be leading Response Biomedical at this exciting time in the evolution of the Company. With partnerships in place with 3M Company, Roche Diagnostics and Shionogi & Co. Ltd., we are poised for strong growth. We also announced a new collaboration to develop a diagnostic for TB. We have begun working with FIND, a Bill and Melinda Gates-funded organization and we are excited about this and other future opportunities we continue to explore.

We are fortunate to be housed in a state-of-the-art manufacturing and product development facility. This global Headquarters will allow us to scale-up manufacturing to meet the needs of our current and future business partners and customers.

We have begun to see our major clinical tests launched into the marketplace by our partners. 3M launched the Flu A+B Test in October 2008 and the RSV test in 2009, while Roche Diagnostics, the largest in vitro diagnostics company in the world, has now launched the cardiovascular line of products. We also saw great strides in China in 2009 by continuing to sell our cardiac products through a strong distributor partner, O&D Biotech Co. Ltd. In February 2010, we added a second such distributor partner in China, Wondfo Biotech Co. Ltd. and we expect growing revenues to continue from this region.

We expect to see continued year-over-year annual revenue growth in 2010.

S. Wayne Kay, CEO